Simnova Biotherapeutics is developing cell therapies to treat cancer. Using cutting-edge technologies and platforms, Simnova is primarily focusing on the development of CAR-T cell therapies for oncology, including hematological malignancy and solid tumors. Simnova has a deep knowledge of tumor immunobiology and is also exploring the development of oncolytic viruses, next generation cytokines and cancer vaccines, some of which are in preclinical studies. Meanwhile, initial CAR-T candidates have entered clinical studies for cancer patients.

<p>Simnova Biotherapeutics is developing cell therapies to treat cancer. Using cutting-edge technologies and platforms, Simnova is primarily focusing on the development of CAR-T cell therapies for oncology, including hematological malignancy and solid tumors. Simnova has a deep knowledge of tumor immunobiology and is also exploring the development of oncolytic viruses, next generation cytokines and cancer vaccines, some of which are in preclinical studies. Meanwhile, initial CAR-T candidates have entered clinical studies for cancer patients.</p>


Simnova Biotherapeutics

Short description:

Drug notes:

Long description:

Jobs: